Clinical Trials Directory

Trials / Conditions / Chronic Hepatitis D Infection

Chronic Hepatitis D Infection

12 registered clinical trials studyying Chronic Hepatitis D Infection — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection
NCT07499544
Huahui HealthPhase 3
RecruitingA Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZU
NCT07298330
Mirum Pharmaceuticals, Inc.Phase 3
RecruitingA Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection
NCT07200908
Mirum Pharmaceuticals, Inc.Phase 3
Active Not RecruitingA Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection
NCT06907290
Mirum Pharmaceuticals, Inc.Phase 2 / Phase 3
RecruitingFind HDV and Determine Its Status in Turkey
NCT06248580
Yaşar Bayındır, MD—
CompletedStudy of Hepalatide in Chronic Hepatitis D(CHD) Patients
NCT05827146
Shanghai HEP Pharmaceutical Co., Ltd.Phase 2
CompletedA Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function
NCT05760300
Gilead SciencesPhase 1
Active Not RecruitingStudy of Bulevirtide in Participants With Chronic Hepatitis D Infection
NCT05718700
Gilead Sciences—
CompletedThe Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-
NCT04638439
PharmaEssentiaPhase 1
CompletedLonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)
NCT02430194
Eiger BioPharmaceuticalsPhase 2
CompletedLonafarnib With and Without Ritonavir in HDV (LOWR-1)
NCT02430181
Eiger BioPharmaceuticalsPhase 2
CompletedMyrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection
NCT02637999
Hepatera Ltd.Phase 1 / Phase 2